申请人:ESTEVE PHARMACEUTICALS, S.A.
公开号:US10421750B2
公开(公告)日:2019-09-24
The present invention relates to substituted morpholine derivatives having pharmacological activity towards the sigma (σ) receptor, to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy, in particular for the treatment of pain.
本发明涉及对 sigma(σ)受体具有药理活性的取代吗啉衍生物,涉及这类化合物的制备工艺,涉及包含这类化合物的药物组合物,还涉及它们在治疗中的用途,特别是用于治疗疼痛。